|
RPT-Seattle Genetics says leukemia drug fails trial
Reuters LOS ANGELES, Sept 13 (Reuters) – Seattle Genetics (SGEN.O) said on Monday it would discontinue development of its experimental drug lintuzumab after a trial found it did not extend the lives of patients with acute myeloid leukemia and its shares fell … Seattle Genetics Shares Drop As Trial Of Leukemia Drug Fails Seattle Genetics will shelve AML drug after PhIIb failure Leukemia Drug Trial Fails |
View full post on Health – Google News
